Search research articles
Contact Us
Filters
Showing results (21-30 of 26) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 26 results.
Antimicrobial Agents and Chemotherapy
|
January 30, 2024
<i>In vitro</i> activity of sulbactam-durlobactam against colistin-resistant and/or cefiderocol-non-susceptible, carbapenem-resistant <i>Acinetobacter baumannii</i> collected in U.S. hospitals
Alina Iovleva, Christi L McElheny, Erin L Fowler, et al.
The Journal of Antimicrobial Chemotherapy
|
February 9, 2024
Differential in vitro susceptibility to ampicillin/ceftriaxone combination therapy among Enterococcus faecalis infective endocarditis clinical isolates
Kevin J Westbrook, Gayatri Shankar Chilambi, Madison E Stellfox, et al.
Mbio
|
March 21, 2022
Carbapenem-Resistant Acinetobacter baumannii in U.S. Hospitals: Diversification of Circulating Lineages and Antimicrobial Resistance
Alina Iovleva, Mustapha M Mustapha, Marissa P Griffith, et al.
Biorxiv : the Preprint Server for Biology
|
July 3, 2023
<i>In vivo</i> evolution of a <i>Klebsiella pneumoniae</i> capsule defect promotes complement-mediated opsono-phagocytosis and persistence during recurrent infection
William Bain, Brian Ahn, Hernán F Peñaloza, et al.
The Journal of Infectious Diseases
|
July 25, 2024
In Vivo Evolution of a Klebsiella pneumoniae Capsule Defect With wcaJ Mutation Promotes Complement-Mediated Opsonophagocytosis During Recurrent Infection
William Bain, Brian Ahn, Hernán F Peñaloza, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 22, 2023
Clinical Outcomes and Bacterial Characteristics of Carbapenem-resistant Acinetobacter baumannii Among Patients From Different Global Regions
Minggui Wang, Lizhao Ge, Liang Chen, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 26) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 26 results.
Antimicrobial Agents and Chemotherapy
|
January 30, 2024
<i>In vitro</i> activity of sulbactam-durlobactam against colistin-resistant and/or cefiderocol-non-susceptible, carbapenem-resistant <i>Acinetobacter baumannii</i> collected in U.S. hospitals
Alina Iovleva, Christi L McElheny, Erin L Fowler, et al.
The Journal of Antimicrobial Chemotherapy
|
February 9, 2024
Differential in vitro susceptibility to ampicillin/ceftriaxone combination therapy among Enterococcus faecalis infective endocarditis clinical isolates
Kevin J Westbrook, Gayatri Shankar Chilambi, Madison E Stellfox, et al.
Mbio
|
March 21, 2022
Carbapenem-Resistant Acinetobacter baumannii in U.S. Hospitals: Diversification of Circulating Lineages and Antimicrobial Resistance
Alina Iovleva, Mustapha M Mustapha, Marissa P Griffith, et al.
Biorxiv : the Preprint Server for Biology
|
July 3, 2023
<i>In vivo</i> evolution of a <i>Klebsiella pneumoniae</i> capsule defect promotes complement-mediated opsono-phagocytosis and persistence during recurrent infection
William Bain, Brian Ahn, Hernán F Peñaloza, et al.
The Journal of Infectious Diseases
|
July 25, 2024
In Vivo Evolution of a Klebsiella pneumoniae Capsule Defect With wcaJ Mutation Promotes Complement-Mediated Opsonophagocytosis During Recurrent Infection
William Bain, Brian Ahn, Hernán F Peñaloza, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 22, 2023
Clinical Outcomes and Bacterial Characteristics of Carbapenem-resistant Acinetobacter baumannii Among Patients From Different Global Regions
Minggui Wang, Lizhao Ge, Liang Chen, et al.
Page
of 3